| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 01/25/2012 | EP2409707A1 Polymer-based sustained release device |
| 01/25/2012 | EP2409702A1 Combination of siloxane and active ingredient for treating dental disorder of hard tissues |
| 01/25/2012 | EP2409688A1 Orally disintegrating tablet |
| 01/25/2012 | EP2409687A1 Water insoluble polymer matrix for drug delivery |
| 01/25/2012 | EP2409686A1 Cell transport compositions and uses thereof |
| 01/25/2012 | EP2409683A1 Stable aqueous formulations comprising poorly water soluble active ingredients |
| 01/25/2012 | EP2409569A2 Method for administering GLP-1 molecules |
| 01/25/2012 | EP2408819A2 High affinity t-cell receptor-like ny-eso-1 peptide antibodies, methods, and uses thereof |
| 01/25/2012 | EP2408480A1 Oct guided tissue ablation |
| 01/25/2012 | EP2408474A2 Compositions and methods for blood-brain barrier delivery of igg-decoy receptor fusion proteins |
| 01/25/2012 | EP2408435A2 Compositions and methods for delivering an agent to a wound |
| 01/25/2012 | EP2408433A1 Pharmaceutical composition comprising aliskiren |
| 01/25/2012 | EP2408429A2 Preparation for external application |
| 01/25/2012 | EP2408426A2 Ophthalmic compositions based on polyunsaturated omega-3 and omega-6 fatty acids |
| 01/25/2012 | EP2280688B1 Aqueous pharmaceutical formulation |
| 01/25/2012 | EP1967188B1 Pharmaceutical preparation of an aqueous solution containing platinum complex |
| 01/25/2012 | EP1901729B1 Pharmaceutical formulations of hdac inhibitors |
| 01/25/2012 | EP1590000B1 Hardenable thermally responsive compositions |
| 01/25/2012 | EP1545613B9 Auristatin conjugates and their use for treating cancer, an autoimmune disease or an infectious disease |
| 01/25/2012 | EP1434597B1 USE OF gp130 ACTIVATORS IN DIABETIC NEUROPATHY |
| 01/25/2012 | EP1192253B1 Icbp90 polypeptide and its fragments and polynucleotides coding for said polypeptides and applications for diagnosing and treating cancer |
| 01/25/2012 | EP1019437B1 Method for the covalent attachment of polysaccharides to protein molecules |
| 01/25/2012 | CN1965834B Enrofolxacn solution containing clustered water used for animal |
| 01/25/2012 | CN1939316B Microsphere containing adriamycin, its usage and preparation |
| 01/25/2012 | CN102333546A Compositions, use and method for the use of surface active proteins in topical drug delivery across keratin |
| 01/25/2012 | CN102333541A Immunogenic composition |
| 01/25/2012 | CN102333535A Magnesium oxide fine granules |
| 01/25/2012 | CN102333529A Coenzyme q10-containing composition for oral ingestion |
| 01/25/2012 | CN102333526A Fast-dissolving oral film for effectively concealing unpleasant tastes |
| 01/25/2012 | CN102333522A Liposomal amphotericin formulation comprising cholesterol for treating fungal infections |
| 01/25/2012 | CN102329438A Magnetic chitosan/doped rare earth compound particles and preparation method thereof |
| 01/25/2012 | CN102329335A Pentaerythritol-based composite lipid and preparation method and application thereof |
| 01/25/2012 | CN102329269A Synthesis of bionic creatininium chloride and catalytic polycondensation method for synthesizing high-molecular-weight polylactic acid |
| 01/25/2012 | CN102327761A Polymer composite micro-bead and preparation method thereof |
| 01/25/2012 | CN102327642A Paste-like bone cement |
| 01/25/2012 | CN102327639A Preparation technique of wound dressing |
| 01/25/2012 | CN102327624A Novel liposome capable of transfecting genes efficiently in vivo and in vitro and preparation method thereof |
| 01/25/2012 | CN102327623A Preparation method of DNA (deoxyribonucleic acid) vaccine nanoparticles containing PLGA (Poly-lactide-co-glycolide) for ND (necastle disease) |
| 01/25/2012 | CN102327622A Method for loading siRNA (small interfering Ribonucleic Acid) by using mesoporous silicon dioxide nanoparticles |
| 01/25/2012 | CN102327621A Phthalocyanine-serum albumin complex and preparation method and application thereof |
| 01/25/2012 | CN102327620A Application of nano-selenium in antineoplastic drug carrier |
| 01/25/2012 | CN102327619A Polyethyleneglycol surface self-assembly gold-base nano antioxidant, preparation method and application thereof |
| 01/25/2012 | CN102327618A Medical penetration enhancer composition |
| 01/25/2012 | CN102327617A Sulfoalkyl ether-cyclodextrin (SAE-CD) composition and preparation method thereof |
| 01/25/2012 | CN102327616A Method for preparing medicinal adjuvant medicinal micro-pill pill core from sucrose and starch by physical mixing method |
| 01/25/2012 | CN102327615A Bone targeting vector and medicament |
| 01/25/2012 | CN102327612A Steady humanized monoclonal antibody preparation |
| 01/25/2012 | CN102327602A Pharmaceutical composition comprising botulinum, a non ionicsurfactant, sodium chloride and sucrose |
| 01/25/2012 | CN102327589A Pill for treating hepatitis |
| 01/25/2012 | CN102327586A Medicament for treating chilblain and preparation method thereof |
| 01/25/2012 | CN102327305A Traditional Chinese medicine oil gauze for treating skin injury and abscess incision and preparation method thereof |
| 01/25/2012 | CN102327296A Propolis powder and preparation method thereof |
| 01/25/2012 | CN102327295A Propolis soft capsule |
| 01/25/2012 | CN102327289A Erythrocyte freeze-dried powder preparation for injection and preparation method thereof |
| 01/25/2012 | CN102327288A Blood platelet freeze-dried powder preparation for injection and preparation method thereof |
| 01/25/2012 | CN102327284A Liquid-phase synthesis method of silver-chitosan and/or chitosan derivative nanocomposite |
| 01/25/2012 | CN102327269A Solid lipidosome preparation of compound cefaclor medicinal composition |
| 01/25/2012 | CN102327267A Pharmaceutical compositions |
| 01/25/2012 | CN102327266A Pharmaceutical composition containing Iloperidone and preparation method thereof |
| 01/25/2012 | CN102327257A Chlocibutamine slow release medicinal composition |
| 01/25/2012 | CN102327253A Minimizing adverse experience associated with oxybutynin therapy |
| 01/25/2012 | CN102327252A Preparation method of soft capsule shell containing levan |
| 01/25/2012 | CN102327251A Preparation method of hard capsule shell containing levan |
| 01/25/2012 | CN102327250A Modified release tamsulosin tablets |
| 01/25/2012 | CN102327249A Lamivudine tablet composition and preparation method thereof |
| 01/25/2012 | CN102327244A Ambroxol hydrochloride orally disintegrating tablet and preparation method thereof |
| 01/25/2012 | CN102327243A Pidotimod chewable tablet |
| 01/25/2012 | CN102327242A Polyethylene glycol-integrated interferon variant lyophilized preparation |
| 01/25/2012 | CN102327241A Polyethylene glycol-integrated interferon variant freeze-dried preparation |
| 01/25/2012 | CN102327238A Levocarnitine composition for injection and preparation method of levocarnitine composition |
| 01/25/2012 | CN102327237A Azasetron hydrochloride lipidosome injection |
| 01/25/2012 | CN102327236A Esomeprazole sodium liposome injection |
| 01/25/2012 | CN102327235A Solid cefixime lipid nanoparticle preparation |
| 01/25/2012 | CN102327234A Racecadotril suspension |
| 01/25/2012 | CN102327233A Dimercaptosuccinic acid granular formulation |
| 01/25/2012 | CN102327232A Preparation method of granular premixing agent |
| 01/25/2012 | CN102327231A Water-soluble phthalocyanine silicon dioxide nanoparticles as well as preparation method and application thereof |
| 01/25/2012 | CN102327230A Protein nanometer granules wrapped with taxane medicaments and preparation method for nanometer granules |
| 01/25/2012 | CN102327229A Pidotimod dry suspension |
| 01/25/2012 | CN102327228A Preparation method of chitosan newcastle disease vaccine nanoparticles |
| 01/25/2012 | CN102327227A Preparation method of polyethylene glycol-poly(gamma-amino-epsilon-caprolactone) nano particle loaded with glycyrrhetic acid |
| 01/25/2012 | CN102327226A Solid cefprozi lipid nanoparticle preparation |
| 01/25/2012 | CN102327225A Tilmicosin liposome injection and preparation method thereof |
| 01/25/2012 | CN102327223A Coenzyme A liposome for injection and preparation method of freeze drying agent thereof |
| 01/25/2012 | CN102327220A Solid loratadine lipidosome preparation |
| 01/25/2012 | CN102327219A Solid esomeprazole magnesium lipidosome preparation |
| 01/25/2012 | CN102327218A Cefdinir liposome solid preparation |
| 01/25/2012 | CN102327217A Solid cefpodoxime proxetil liposome preparation |
| 01/25/2012 | CN102327215A Medecamycin nanoemulsion antibacterial drug and preparation method thereof |
| 01/25/2012 | CN102327213A Triamcinolone acetonaide acetate nano eye drops and preparation method thereof |
| 01/25/2012 | CN102327211A Pharmaceutical manufacturing process for heat sterilized glucocorticoid suspensions |
| 01/25/2012 | CN102327210A Vinpocetine suspension injection |
| 01/25/2012 | CN102327209A Preparation method of hydroxyethyl starch 130/0.4 sodium chloride injection |
| 01/25/2012 | CN102327208A Vinpocetine polymer micelle preparation and preparation method thereof |
| 01/25/2012 | CN102058584B Preparation method of potassium clavulanate/microcrystalline cellulose composition |
| 01/25/2012 | CN102018780B Skin bacteriostatic agent and preparation method thereof |
| 01/25/2012 | CN101979091B Preparation method of calcium phosphate nano medicament-carrying systems |
| 01/25/2012 | CN101926821B Drug composition for targeted release of trace elements and preparation method and application thereof |
| 01/25/2012 | CN101919812B Novel formulation of piperazine ferulate and preparation method thereof |
| 01/25/2012 | CN101906146B Conjugate produced by coupling Arg-Gly-Asp-Ser chain with two fatty alcohol chains through Asp, synthesis of Arg-Gly-Asp-Ser chain and fatty alcohol chains and application in medicine |